{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:37:49Z","timestamp":1790937469938,"version":"4.1.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The pathogenesis of chronic lymphocytic leukemia (CLL) is unknown but may involve aberrant activation of signaling pathways. Somatic hypermutations in rearranged immunoglobulin heavy-chain (IgVH) genes allow a division of CLL patients into 2 categories: mutated IgVH genes are associated with an indolent disease, whereas unmutated IgVH genes define an aggressive form. Using differential display to compare gene expression in CLL cells with and without IgVH hypermutations, we identified a novel gene, CLL up-regulated gene 1 (CLLU1), that was highly up-regulated in CLL cells without IgVH hypermutations. CLLU1 mapped to chromosome 12q22, within a cluster of genes that are active in germinal center B cells. However, appreciable levels of CLLU1 were detectable only in CLL cells and not in a panel of normal tissue extracts or in any other tested hematologic malignancy. High expression of CLLU1 in CLL samples occurred irrespective of trisomy 12 or large chromosomal rearrangements. CLLU1 encodes 6 mRNAs with no sequence homology to any known gene, and most transcripts appear to be noncoding. Two transcripts, however, potentially encode a peptide with remarkable structural similarity to human interleukin 4. These data, in particular the unique and restricted expression pattern, suggest that CLLU1 is the first disease-specific gene identified in CLL.<\/jats:p>","DOI":"10.1182\/blood-2005-07-2615","type":"journal-article","created":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T01:52:45Z","timestamp":1134093165000},"page":"2904-2911","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":50,"title":["Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia"],"prefix":"10.1182","volume":"107","author":[{"given":"Anne Mette","family":"Buhl","sequence":"first","affiliation":[{"name":"From The Leukemia Laboratory, the Granulocyte Laboratory, Department of Hematology, Department of Pathology, and The University Department of Growth and Reproduction, Rigshospitalet; and the Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Copenhagen, DK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Jurlander","sequence":"additional","affiliation":[{"name":"From The Leukemia Laboratory, the Granulocyte Laboratory, Department of Hematology, Department of Pathology, and The University Department of Growth and Reproduction, Rigshospitalet; and the Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Copenhagen, DK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming S.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"From The Leukemia Laboratory, the Granulocyte Laboratory, Department of Hematology, Department of Pathology, and The University Department of Growth and Reproduction, Rigshospitalet; and the Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Copenhagen, DK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Ottesen","sequence":"additional","affiliation":[{"name":"From The Leukemia Laboratory, the Granulocyte Laboratory, Department of Hematology, Department of Pathology, and The University Department of Growth and Reproduction, Rigshospitalet; and the Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Copenhagen, DK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack B.","family":"Cowland","sequence":"additional","affiliation":[{"name":"From The Leukemia Laboratory, the Granulocyte Laboratory, Department of Hematology, Department of Pathology, and The University Department of Growth and Reproduction, Rigshospitalet; and the Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Copenhagen, DK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Mette","family":"Gjerdrum","sequence":"additional","affiliation":[{"name":"From The Leukemia Laboratory, the Granulocyte Laboratory, Department of Hematology, Department of Pathology, and The University Department of Growth and Reproduction, Rigshospitalet; and the Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Copenhagen, DK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian V.","family":"Hansen","sequence":"additional","affiliation":[{"name":"From The Leukemia Laboratory, the Granulocyte Laboratory, Department of Hematology, Department of Pathology, and The University Department of Growth and Reproduction, Rigshospitalet; and the Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Copenhagen, DK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Leffers","sequence":"additional","affiliation":[{"name":"From The Leukemia Laboratory, the Granulocyte Laboratory, Department of Hematology, Department of Pathology, and The University Department of Growth and Reproduction, Rigshospitalet; and the Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Copenhagen, DK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020071614004282200_REF1","doi-asserted-by":"crossref","unstructured":"Caligaris-Cappio F, Hamblin TJ. B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol. 1999;17: 399-408.","DOI":"10.1200\/JCO.1999.17.1.399"},{"key":"2020071614004282200_REF2","doi-asserted-by":"crossref","unstructured":"Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343: 1910-1916.","DOI":"10.1056\/NEJM200012283432602"},{"key":"2020071614004282200_REF3","doi-asserted-by":"crossref","unstructured":"Stilgenbauer S, Lichter P, Dohner H. Genetic features of B-cell chronic lymphocytic leukemia. Rev Clin Exp Hematol. 2000;4: 48-72.","DOI":"10.1046\/j.1468-0734.2000.00003.x"},{"key":"2020071614004282200_REF4","doi-asserted-by":"crossref","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194: 1625-1638.","DOI":"10.1084\/jem.194.11.1625"},{"key":"2020071614004282200_REF5","doi-asserted-by":"crossref","unstructured":"Haslinger C, Schweifer N, Stilgenbauer S, et al. Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. J Clin Oncol. 2004;22: 3937-3949.","DOI":"10.1200\/JCO.2004.12.133"},{"key":"2020071614004282200_REF6","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194: 1639-1647.","DOI":"10.1084\/jem.194.11.1639"},{"key":"2020071614004282200_REF7","doi-asserted-by":"crossref","unstructured":"Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94: 1840-1847.","DOI":"10.1182\/blood.V94.6.1840"},{"key":"2020071614004282200_REF8","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94: 1848-1854.","DOI":"10.1182\/blood.V94.6.1848"},{"key":"2020071614004282200_REF9","doi-asserted-by":"crossref","unstructured":"Heintel D, Kienle D, Shehata M, et al. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia. 2005;19: 1216-1223.","DOI":"10.1038\/sj.leu.2403748"},{"key":"2020071614004282200_REF10","doi-asserted-by":"crossref","unstructured":"Oppezzo P, Vasconcelos Y, Settegrana C, et al. The LPL\/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood. 2005;106: 650-657.","DOI":"10.1182\/blood-2004-08-3344"},{"key":"2020071614004282200_REF11","doi-asserted-by":"crossref","unstructured":"Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003;101: 4944-4951.","DOI":"10.1182\/blood-2002-10-3306"},{"key":"2020071614004282200_REF12","doi-asserted-by":"crossref","unstructured":"Rassenti LZ, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med. 2004;351: 893-901.","DOI":"10.1056\/NEJMoa040857"},{"key":"2020071614004282200_REF13","unstructured":"Gjerdrum LM, Hamilton-Dutoit S. Laser-assisted microdissection of membrane-mounted tissue sections. Methods Mol Biol. 2005;293: 127-138."},{"key":"2020071614004282200_REF14","doi-asserted-by":"crossref","unstructured":"Gjerdrum LM, Sorensen BS, Kjeldsen E, Sorensen FB, Nexo E, Hamilton-Dutoit S. Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2\/neu analysis. J Mol Diagn. 2004;6: 42-51.","DOI":"10.1016\/S1525-1578(10)60490-4"},{"key":"2020071614004282200_REF15","doi-asserted-by":"crossref","unstructured":"Jorgensen M, Bevort M, Kledal TS, Hansen BV, Dalgaard M, Leffers H. Differential display competitive polymerase chain reaction: an optimal tool for assaying gene expression. Electrophoresis. 1999;20: 230-240.","DOI":"10.1002\/(SICI)1522-2683(19990201)20:2<230::AID-ELPS230>3.0.CO;2-I"},{"key":"2020071614004282200_REF16","doi-asserted-by":"crossref","unstructured":"Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992;257: 967-971.","DOI":"10.1126\/science.1354393"},{"key":"2020071614004282200_REF17","unstructured":"Comparative CT Method of Relative Quantification. ABI Prism 7900HT Sequence Detection System User Guide: E11-E13."},{"key":"2020071614004282200_REF18","doi-asserted-by":"crossref","unstructured":"van de Rijke FM, Vrolijk H, Sloos W, Tanke HJ, Raap AK. Sample preparation and in situ hybridization techniques for automated molecular cytogenetic analysis of white blood cells. Cytometry. 1996;24: 151-157.","DOI":"10.1002\/(SICI)1097-0320(19960601)24:2<151::AID-CYTO7>3.0.CO;2-M"},{"key":"2020071614004282200_REF19","doi-asserted-by":"crossref","unstructured":"Fidlerova H, Senger G, Kost M, Sanseau P, Sheer D. Two simple procedures for releasing chromatin from routinely fixed cells for fluorescence in situ hybridization. Cytogenet Cell Genet. 1994;65: 203-205.","DOI":"10.1159\/000133632"},{"key":"2020071614004282200_REF20","unstructured":"Trask BJ, Massa H, Kenwrick S, Gitschier J. Mapping of human chromosome Xq28 by two-color fluorescence in situ hybridization of DNA sequences to interphase cell nuclei. Am J Hum Genet. 1991;48: 1-15."},{"key":"2020071614004282200_REF21","doi-asserted-by":"crossref","unstructured":"Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234: 779-815.","DOI":"10.1006\/jmbi.1993.1626"},{"key":"2020071614004282200_REF22","doi-asserted-by":"crossref","unstructured":"Rouault JP, Rimokh R, Tessa C, et al. BTG1, a member of a new family of antiproliferative genes. EMBO J. 1992;11: 1663-1670.","DOI":"10.1002\/j.1460-2075.1992.tb05213.x"},{"key":"2020071614004282200_REF23","doi-asserted-by":"crossref","unstructured":"Mu FT, Callaghan JM, Steele-Mortimer O, et al. EEA1, an early endosome-associated protein: EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine \u201cfingers\u201d and contains a calmodulin-binding IQ motif. J Biol Chem. 1995;270: 13503-13511.","DOI":"10.1074\/jbc.270.22.13503"},{"key":"2020071614004282200_REF24","doi-asserted-by":"crossref","unstructured":"Muller T, Oehlenschlager F, Buehner M. Human interleukin-4 and variant R88Q: phasing X-ray diffraction data by molecular replacement using X-ray and nuclear magnetic resonance models. J Mol Biol. 1995;247: 360-372.","DOI":"10.1006\/jmbi.1994.0144"},{"key":"2020071614004282200_REF25","doi-asserted-by":"crossref","unstructured":"Hage T, Sebald W, Reinemer P. Crystal structure of the interleukin-4\/receptor alpha chain complex reveals a mosaic binding interface. Cell. 1999;97: 271-281.","DOI":"10.1016\/S0092-8674(00)80736-9"},{"key":"2020071614004282200_REF26","doi-asserted-by":"crossref","unstructured":"Merup M, Juliusson G, Wu X, et al. Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia. Eur J Haematol. 1997;58: 174-180.","DOI":"10.1111\/j.1600-0609.1997.tb00944.x"},{"key":"2020071614004282200_REF27","doi-asserted-by":"crossref","unstructured":"Dierlamm J, Wlodarska I, Michaux L, et al. FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial trisomy 12. Genes Chromosomes Cancer. 1997;20: 155-166.","DOI":"10.1002\/(SICI)1098-2264(199710)20:2<155::AID-GCC6>3.0.CO;2-2"},{"key":"2020071614004282200_REF28","doi-asserted-by":"crossref","unstructured":"Kienle DL, Korz C, Hosch B, et al. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes. J Clin Oncol. 2005;23: 3780-3922.","DOI":"10.1200\/JCO.2005.02.568"},{"key":"2020071614004282200_REF29","doi-asserted-by":"crossref","unstructured":"Winkler D, Schneider C, Krober A, et al. Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). Leukemia. 2005;19: 1211-1215.","DOI":"10.1038\/sj.leu.2403778"},{"key":"2020071614004282200_REF30","doi-asserted-by":"crossref","unstructured":"Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med. 1992;176: 1319-1326.","DOI":"10.1084\/jem.176.5.1319"},{"key":"2020071614004282200_REF31","unstructured":"Huang RW, Tsuda H, Takatsuki K. Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells. Int J Hematol. 1993;58: 83-92."},{"key":"2020071614004282200_REF32","doi-asserted-by":"crossref","unstructured":"Jewell AP, Worman CP, Lydyard PM, Yong KL, Giles FJ, Goldstone AH. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br J Haematol. 1994;88: 268-274.","DOI":"10.1111\/j.1365-2141.1994.tb05017.x"},{"key":"2020071614004282200_REF33","doi-asserted-by":"crossref","unstructured":"Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med. 1993;177: 213-218.","DOI":"10.1084\/jem.177.1.213"},{"key":"2020071614004282200_REF34","doi-asserted-by":"crossref","unstructured":"Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell\u2032Aquila M, Kipps TJ. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood. 2000;96: 2655-2663.","DOI":"10.1182\/blood.V96.8.2655"},{"key":"2020071614004282200_REF35","doi-asserted-by":"crossref","unstructured":"Munk Pedersen I, Reed J. Microenvironmental interactions and survival of CLL B-cells. Leuk Lymphoma. 2004;45: 2365-2372.","DOI":"10.1080\/10428190412331272703"},{"key":"2020071614004282200_REF36","doi-asserted-by":"crossref","unstructured":"Panayiotidis P, Ganeshaguru K, Jabbar SA, Hoff-brand AV. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol. 1993;85: 439-445.","DOI":"10.1111\/j.1365-2141.1993.tb03330.x"},{"key":"2020071614004282200_REF37","doi-asserted-by":"crossref","unstructured":"Kay NE, Pittner BT. IL-4 biology: impact on normal and leukemic CLL B cells. Leuk Lymphoma. 2003;44: 897-903.","DOI":"10.1080\/1042819031000068007"},{"key":"2020071614004282200_REF38","doi-asserted-by":"crossref","unstructured":"Lundin J, Kimby E, Bergmann L, Karakas T, Mellstedt H, Osterborg A. Interleukin 4 therapy for patients with chronic lymphocytic leukaemia: a phase I\/II study. Br J Haematol. 2001;112: 155-160.","DOI":"10.1046\/j.1365-2141.2001.02525.x"},{"key":"2020071614004282200_REF39","unstructured":"Woessmann W, Damm-Welk C, Fuchs U, Borkhardt A. RNA interference: new mechanisms for targeted treatment? Rev Clin Exp Hematol. 2003;7: 270-291."},{"key":"2020071614004282200_REF40","doi-asserted-by":"crossref","unstructured":"Mello CC, Conte D Jr. Revealing the world of RNA interference. Nature. 2004;431: 338-342.","DOI":"10.1038\/nature02872"},{"key":"2020071614004282200_REF41","doi-asserted-by":"crossref","unstructured":"Vassaux G, Martin-Duque P. Use of suicide genes for cancer gene therapy: study of the different approaches. Expert Opin Biol Ther. 2004;4: 519-530.","DOI":"10.1517\/14712598.4.4.519"},{"key":"2020071614004282200_REF42","doi-asserted-by":"crossref","unstructured":"Wendtner CM, Kofler DM, Mayr C, Bund D, Hallek M. The potential of gene transfer into primary B-CLL cells using recombinant virus vectors. Leuk Lymphoma. 2004;45: 897-904.","DOI":"10.1080\/10428190310001638896"},{"key":"2020071614004282200_REF43","unstructured":"Buhl AM, Jurlander J, Geisler CH, et al. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia. Eur J Haematol. 2006; January 2: prepublished as DOI: 10.1111\/j.0902-4441.2005. t01-1-EJH2530.x."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/7\/2904\/1339114\/zh800706002904.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/7\/2904\/1339114\/zh800706002904.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:10:51Z","timestamp":1594948251000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/7\/2904\/132095\/Identification-of-a-gene-on-chromosome-12q22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,1]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-07-2615","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,1]]}}}